Blog
RSS FeedPosted by Michael Wonder on 21 Dec 2020
Newly approved treatment could save a young child in Edmonton with a rare disease. It costs 2.8 million dollars per dose.
19 December 2020 - Reign Johnston is a happy baby who enjoys painting as much as playing with toys. His green ...
Posted by Michael Wonder on 30 Nov 2020
Canada to Trump: you can't take our prescription drugs
30 November 2020 - Canada is putting the kibosh on President Donald Trump's efforts to lower drug prices by importing ...
Posted by Michael Wonder on 10 Nov 2020
Manufacturer moves to bring 'life-changing' cystic fibrosis drugs to Canada
10 November 2020 - A pharmaceutical company says it's taking steps to bring cystic fibrosis drugs to Canada in a ...
Posted by Michael Wonder on 09 Nov 2020
Eligible patients living with rare debilitating genetic disorder are one step closer to having access to first-of-its-kind treatment option
5 November 2020 - Takeda Canada is pleased to announce it has completed the Letter of Intent with the pan Canadian ...
Posted by Michael Wonder on 01 Nov 2020
John Ivison: The math of saving lives — Canada's drug battle leaves patients caught in the middle
31 October 2020 - By cold mathematics, spending $1.3 billion to transform the lives of 3,700 Canadians might seem a ...
Posted by Michael Wonder on 27 Oct 2020
Mavenclad (cladribine tablets) is available through public drug plans for the majority of eligible Canadians with relapsing-remitting multiple sclerosis
27 October 2020 - EMD Serono is pleased to announce that eligible patients have access to Mavenclad (cladribine tablets) through ...
Posted by Michael Wonder on 22 Oct 2020
Patients, health organisations band together to bring breakthrough treatments to Canada sooner
21 October 2020 - Thirteen health charities and patient groups are calling on the Canadian government to improve access to ...
Posted by Michael Wonder on 21 Oct 2020
Canadian baby with spinal muscular atrophy to get ‘world’s most expensive drug’
20 October 2020 - A little over a year ago, the idea of raising US$2.125 million to receive the “world’s ...
Posted by Michael Wonder on 20 Oct 2020
Health charities and patient groups join together to protect access to breakthrough medical treatments in Canada
19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices ...
Posted by Michael Wonder on 04 Oct 2020
Ruzurgi now available to Canadian Lambert-Eaton myasthenic syndrome patients
25 September 2020 - Médunik Canada is extremely pleased to announce that its new orphan disease product Ruzurgi (amifampridine) is now ...
Posted by Michael Wonder on 24 Sep 2020
Bausch Health announces Vyzulta (latanoprostene bunod 0.024% ophthalmic solution) is now approved in seven countries
24 September 2020 - Recent access wins also make Vyzulta available to more Americans and Canadians. ...
Posted by Michael Wonder on 19 Aug 2020
Launch of two biosimilars
19 August 2020 - Sandoz Canada announces an agreement with the pCPA and the launches of Ziextenzo and Riximyo. ...
Posted by Michael Wonder on 12 Aug 2020
Rare disease drugs strategy, standard coverage in CLHIA’s 2020 budget wish list
12 August 2020 - The Canadian Life and Health Insurance Association is recommending the federal government develop a strategy for ...
Posted by Michael Wonder on 10 Aug 2020
B.C. family nearing finish in race to raise $2.8 million to treat baby's rare disease
8 August 2020 - Parents hope funds will pay for expensive therapy not approved in Canada for type 1 spinal muscular ...
Posted by Michael Wonder on 26 Jul 2020
'I need something to move forward,' says Edmonton mom waiting for approval for son's life saving treatment
24 July 2020 - The family of a little boy in need of a $3 million treatment says they have ...